Clinical Trial Update: Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1) [Phase 1]

View source ↗

Summary

Phase 1 dose-range study evaluating a Norovirus GII.4 CIN-1 challenge pool; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Norovirus Infection

Drugs mentioned

• Norovirus GII.4 CIN-1 Challenge Pool

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Norovirus Infections | Phase 1 | Status: COMPLETED